Moizerto (difamilast) / Otsuka, Medimetriks  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Moizerto (difamilast) / Otsuka, Medimetriks
NCT02068352 / 2013-003899-12: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

Completed
2
121
Europe, US, RoW
OPA-15406, Vehicle ointment
Otsuka Pharmaceutical Development & Commercialization, Inc.
Atopic Dermatitis
01/15
02/15
NCT02914548: Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

Completed
2
200
Japan
OPA-15406, Placebo
Otsuka Pharmaceutical Co., Ltd.
Atopic Dermatitis
06/17
06/17
NCT03018691: Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

Completed
2
73
Japan
OPA-15406, Placebos
Otsuka Pharmaceutical Co., Ltd.
Atopic Dermatitis
06/17
06/17
NCT02945657: Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis

Completed
2
32
US, RoW
MM36 topical ointment, 1%, OPA-15406
Medimetriks Pharmaceuticals, Inc
Atopic Dermatitis
06/17
06/17

Download Options